Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shen Tan

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Frontiers in Surgery|October 21, 2022
A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyondJeffrey J Leow, Wei Shen Tan, Wei Phin Tan, et al.
Cancers|July 2, 2021
Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta-AnalysisVinson Wai-Shun Chan, Wei Shen Tan, Aqua Asif, et al.
European Urology|October 3, 2018
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled TrialWei Shen Tan, Anesh Panchal, Laura Buckley, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
The Journal of Urology|December 28, 2020
Evaluation of the New American Urological Association Guidelines Risk Classification for HematuriaSolomon L Woldu, Casey K Ng, Ronald K Loo, et al.
Clinical Epigenetics|February 7, 2017
UroMark-a urinary biomarker assay for the detection of bladder cancerAndrew Feber, Pawan Dhami, Liqin Dong, et al.
European Urology Oncology|October 11, 2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer GroupRoger Li, Patrick J Hensley, Marko Babjuk, et al.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Frontiers in Surgery|October 21, 2022
A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyondJeffrey J Leow, Wei Shen Tan, Wei Phin Tan, et al.
Cancers|July 2, 2021
Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta-AnalysisVinson Wai-Shun Chan, Wei Shen Tan, Aqua Asif, et al.
European Urology|October 3, 2018
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled TrialWei Shen Tan, Anesh Panchal, Laura Buckley, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
The Journal of Urology|December 28, 2020
Evaluation of the New American Urological Association Guidelines Risk Classification for HematuriaSolomon L Woldu, Casey K Ng, Ronald K Loo, et al.
Clinical Epigenetics|February 7, 2017
UroMark-a urinary biomarker assay for the detection of bladder cancerAndrew Feber, Pawan Dhami, Liqin Dong, et al.
European Urology Oncology|October 11, 2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer GroupRoger Li, Patrick J Hensley, Marko Babjuk, et al.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
Pageof 15